Companies / NYR

NYRADA INC.

ASX:NYRPharmaceuticals, Biotechnology & Life Sciences
247.6M shares on issueASX (delayed) · snapshot 11 Sept 2026292.7M fully diluted+18.2% if every option and right converts$0.72price · delayed$178.3Mmarket cap · indicative

Today’s holders own 84.6% of what they think they own, once every option and right converts.

Moderate
Dilution risk

Share count grew 36% in 24 months; runway 4–8 quarters; 2 cash raises in 24 months

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway4.4 quarters of funding
Share-count growth (24m)35.9%
Raise cadence (24m)2 cash raises
Options & rights overhang18.2% of shares
In-the-money supply7.1% of shares
Pending proposed issuesnone

NYRADA INC.'s ordinary share count grew 35.9% between June 2024 and August 2026, reaching 248M shares. In the past 24 months, the company raised capital twice for total disclosed proceeds of A$11.7M, most recently through a placement in July 2025 that yielded A$8.2M. Options and rights on issue could convert into 45M new shares, representing 18.2% of the current share count, of which 7% are in the money, with the nearest expiry in June 2027. As of the June 2026 quarter, NYRADA INC. held A$7.1M in available cash, sufficient to cover approximately 4.4 quarters of operations. No proposed securities issues are currently pending.

AI-generated summary of this page's cited filings · updated 8 Sept 2026
Get told when this changes
Set up alerts
Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.
18.2%
Options & rights overhang
7.1%
In-the-money supply
0
Raises · last 12 months
4.4 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 247.6M per ASX (delayed) (snapshot 11 Sept 2026).
210M220M230M240M250MDec 24Oct 25Sept 26Cash raise · 30 July 2025247.6M

Cash runway

4.4 qtrs
More than four quarters of funding at the recent spend rate.
Funds operations to about July 2027 at the reported spend rate.
$7.1M cash after burn from the quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds. Filed with the quarterly report: $8.4M cash at quarter end (item 4.6). Our figure above carries the filed quarter-end balance forward at the reported spend rate and adds announced raise proceeds.
Free account
14 quarters on record — Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
24 Aug 20262A · quoted issueNYR : CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED247.6MAppendix 2A
30 June 20263H · cancellationNYR : CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED245.5MAppendix 3H
29 June 20262A · quoted issueNYR : CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED246.9MAppendix 2A
29 June 20262A · quoted issueNYR : CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED245.7MAppendix 2A
16 June 20262A · quoted issueNYR : CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED245.5MAppendix 2A
Free account
45 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Capital raises

2 cash raises in the last 24 months · 0 in the last 12 months

every 9.1 monthsaverage gap between raises
13.4 monthssince the most recent
25 Oct 2024 – 30 July 2025first to most recent in this window
$8.3M
Placement
30 July 2025 ACTIVE
Free account
9 raises on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

10.3M of option supply could convert within 12 months — 4.2% of shares on issue
10.3M in the money, expiring in the window
Out-of-the-money options are excluded — at today’s price they expire rather than convert. So is condition-triggered supply, which has no expiry and no price, and convertibles that convert on their own terms rather than on a date.
Free account
11 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

About 99% of the 15% placement capacity left — about 1% used by Appendix 3B filings in the last 12 months (estimate, as at 2026-09-12). Holder-approved issues and any later ratification are not deducted, so the true headroom can be higher.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

18.2%
Options & rights overhang · of current shares
7.1%
In-the-money supply · at current price
45.1M
Potential new shares
June 2027
Nearest expiry
What a price move would switch on
22.6M45.1M$0.72 now0.25× today ($0.18) — 3.3M of the priced supply in the money, 1.3% of shares on issue0.5× today ($0.36) — 10.7M of the priced supply in the money, 4.3% of shares on issue0.75× today ($0.54) — 17.6M of the priced supply in the money, 7.1% of shares on issue1× today ($0.72) — 17.6M of the priced supply in the money, 7.1% of shares on issue1.25× today ($0.90) — 26.6M of the priced supply in the money, 10.8% of shares on issue1.5× today ($1.08) — 26.6M of the priced supply in the money, 10.8% of shares on issue2× today ($1.44) — 26.6M of the priced supply in the money, 10.8% of shares on issue3× today ($2.16) — 26.6M of the priced supply in the money, 10.8% of shares on issue5× today ($3.60) — 26.6M of the priced supply in the money, 10.8% of shares on issue10× today ($7.20) — 26.6M of the priced supply in the money, 10.8% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

At $0.72 today, 17.6M securities are in the money (7.1% of shares on issue). No more priced supply until 1.25× today’s price, which takes it to 26.6M (10.8% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 1.2M (2.7% of the supply above) states a nil exercise price — nothing is paid to convert it, so no share price switches it on or off. It is the flat band, and it is not part of the in-the-money figure.
  • 17.3M (38.3% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
CodeSecurityTypeExercise priceExpiryOn issueSource
NYRAJOptionsPrice-triggered$0.1430 June 20273.3MFiling
NYRAROptionsPrice-triggered$0.4522 Aug 20276.9MFiling
NYRAKOptionsPrice-triggered$0.2031 Dec 20271.8MFiling
NYRASOptionsPrice-triggered$0.8012 Nov 20293.0MFiling
NYRAVOptionsPrice-triggeredNil12 Nov 2030600kFiling
NYRATOptionsPrice-triggered$0.8012 Nov 20303.0MFiling
NYRAOOptionsPrice-triggered$0.1911 June 20311.6MFiling
NYRAWOptionsPrice-triggeredNil12 Nov 2031600kFiling
NYRAUOptionsPrice-triggered$0.8012 Nov 20313.0MFiling
NYRAPOptionsPrice-triggered$0.1911 June 20321.8MFiling
NYRAQOptionsPrice-triggered$0.1930 June 20332.1MFiling
NYRAIOptionsPrice-triggered——17.3MFiling

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.

Free account
12 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
11 June 2026James BonnarBuy on-market4k——$2k3Y notice
11 June 2026James BonnarBuy on-market7k——$3k3Y notice
10 June 2026James BonnarBuy on-market6k——$3k3Y notice
Free account
39 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

27 Aug 2026Change in substantial holding - M Azzi
24 Aug 2026Cleansing Statement
24 Aug 2026Application for quotation of securities - NYR
20 Aug 2026$PXolatryp Demonstrates Cardioprotection in Preclinical Study
18 Aug 2026Nyrada Full Year Results FY2026
18 Aug 2026Annual Report for year ended 30 June 2026
18 Aug 2026$PPreliminary Final Report
18 Aug 2026Appendix 4G and Corporate Governance Statement
5 Aug 2026Change in substantial holding - M Azzi
4 Aug 2026CSANZ26 Conference Poster
26 July 2026$PQuarterly Activities Report and Appendix 4C
15 July 2026$PResponse to ASX Price Query
15 July 2026Change in substantial holding - M Azzi
5 July 2026PROTECT-MI Phase IIa Clinical Trial Update No 2
30 June 2026Notification of cessation of securities - NYR
29 June 2026Cleansing Statement
29 June 2026Application for quotation of securities - NYR
29 June 2026Cleansing Statement
29 June 2026Application for quotation of securities - NYR
16 June 2026Cleansing Statement

Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.